latest news releases from the newsroom
ZAP Files Request for Nasdaq Listing Qualification Panel Hearing
SEBASTOPOL, Calif., March 28, 2002 (PRIMEZONE) -- ZAP (Nasdaq:ZAPPQ) today announced that on March 21, 2002, the listing qualifications section of Nasdaq notified ZAP that Nasdaq intends to delist ZAP from The Nasdaq Stock Market for failure to comply with Marketplace Rules 4330(a)(1), 4330(a)(3), 4310(c)(2)(B and 4310(c)(13).
E-Rex, Inc. Revises Quarterly and Annual Reports Based on SEC Comments
MIAMI, March 28, 2002 (PRIMEZONE) -- Today, E-Rex, Inc. (OTCBB:EREX) restated its 10-QSB Quarterly Statement for the quarter ended September 2000 and the 10-KSB Annual Statement for the period ended December 2000. The Company intends to also restate March, June and September 2001 quarterly statements over the next few days. These filings are being restated to clarify and provide additional information as required by the Securities and Exchange Commission in comments to the SB-2 filings which have been made by the Company. References throughout the financial statements are accurate as of the date originally filed. The Company has not undertaken to update all of the information in the reports, but instead has updated only those areas requested by the Commission.
Adkins, Kelston, & Zavez, P.C.
Adkins, Kelston & Zavez, P.C. Announces That it is Investigating Securities Irregularities Involving Measurement Specialties, Inc. -- MSS
BOSTON, March 28, 2002 (PRIMEZONE) -- The law firm of Adkins, Kelston & Zavez, P.C. today announced that shareholders of Measurement Specialties, Inc. (AMEX:MSS), a New Jersey-based maker of sensor-based electronic measuring devices, may have claims against the company for violation of federal securities laws. According to a February 15, 2002 press release, the Corporation announced that it expected a significant loss for the quarter ending December 31, 2001 and that it expected to restate its financial statements for the quarter ending September 30, 2001.
PharmChem Announces Closing of Sale of Medscreen, Ltd.
HALTOM CITY, Texas, March 28, 2002 (PRIMEZONE) -- PharmChem Inc. (Nasdaq:PCHM) today announced that it had completed the sale of Medscreen, Ltd., its London-based wholly owned subsidiary for approximately $9.9 million. The proceeds will be used to pay down debt and for general corporate purposes. The transaction will be recorded in the first quarter of 2002.
UTi Worldwide to Report Fiscal 2002 Fourth Quarter and Year End Results on April 3
RANCHO DOMINGUEZ, Calif., March 28, 2002 (PRIMEZONE) -- UTi Worldwide Inc. (Nasdaq:UTIW) today announced that, prior to market open on Wednesday, April 3, 2002, the company will release financial results for its fourth fiscal quarter and year ended January 31, 2002. The company also said that it will host an investor conference call the same day at 7:00 a.m. PT (10:00 a.m. ET) to review the company's financials and operations for the quarter.